Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$516.18
Market cap
$197.44B
P/E Ratio
32.28
Dividend/share
$1.52
EPS
$15.99
Enterprise value
$228.11B
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .
Highlights
The stock's price to earnings (P/E) is 11% less than its last 4 quarters average of 36.0
The company's equity rose by 8% YoY and by 3.3% QoQ
Thermo Fisher Scientific's quick ratio has decreased by 10% from the previous quarter
Thermo Fisher Scientific's revenue has decreased by 2.4% YoY
Key stats
What are the main financial stats of TMO
Market
Valuations
Earnings
Shares outstanding
382.5M
Market cap
$197.44B
Enterprise value
$228.11B
Price to earnings (P/E)
32.28
Price to book (P/B)
4.02
Price to sales (P/S)
4.65
EV/EBIT
27.68
EV/EBITDA
19.93
EV/Sales
5.38
Revenue
$42.37B
EBIT
$8.24B
EBITDA
$11.45B
Free cash flow
$7.83B
Per share
Balance sheet
Liquidity
EPS
$15.99
Free cash flow per share
$20.49
Book value per share
$128.25
Revenue per share
$110.92
TBVPS
$97.84
Total assets
$100.36B
Total liabilities
$51.39B
Debt
$35.31B
Equity
$48.99B
Working capital
$9.18B
Debt to equity
0.72
Current ratio
1.63
Quick ratio
1.02
Net debt/EBITDA
2.68
Margins
Efficiency
Dividend
EBITDA margin
27%
Gross margin
40.8%
Net margin
14.5%
Operating margin
16.9%
Return on assets
6.2%
Return on equity
13%
Return on invested capital
15.7%
Return on capital employed
9.6%
Return on sales
19.4%
Dividend yield
0.29%
DPS
$1.52
Payout ratio
9.5%
TMO stock price
How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.65%
1 week
-3.16%
1 month
-13.3%
1 year
7%
YTD
-2.75%
QTD
-16.55%
Financial performance
How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.37B
Gross profit
$17.27B
Operating income
$7.18B
Net income
$6.14B
Gross margin
40.8%
Net margin
14.5%
Thermo Fisher Scientific's operating margin has increased by 7% YoY
The net margin has increased by 6% YoY
The operating income has grown by 4.5% YoY
Thermo Fisher Scientific's net income has increased by 3.3% YoY
Growth
What is Thermo Fisher Scientific's growth rate over time
Valuation
What is Thermo Fisher Scientific stock price valuation
P/E
32.28
P/B
4.02
P/S
4.65
EV/EBIT
27.68
EV/EBITDA
19.93
EV/Sales
5.38
The stock's price to earnings (P/E) is 11% less than its last 4 quarters average of 36.0
TMO's EPS is up by 4.2% year-on-year
The P/B is 20% below the 5-year quarterly average of 5.0 and 13% below the last 4 quarters average of 4.6
The company's equity rose by 8% YoY and by 3.3% QoQ
The P/S is 11% below the 5-year quarterly average of 5.2 and 9% below the last 4 quarters average of 5.1
Thermo Fisher Scientific's revenue has decreased by 2.4% YoY
Efficiency
How efficient is Thermo Fisher Scientific business performance
TMO's ROS is up by 12% year-on-year
The ROE has contracted by 4.4% YoY and by 3.7% from the previous quarter
TMO's return on invested capital is up by 3.3% year-on-year
TMO's ROA is down by 3.1% from the previous quarter
Dividends
What is TMO's dividend history
DPS
$1.52
Dividend yield
0.29%
Payout ratio
9.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Thermo Fisher Scientific financials performed over time
The total assets is 95% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has decreased by 10% from the previous quarter
The current ratio has declined by 5% since the previous quarter
The debt is 28% lower than the equity
Thermo Fisher Scientific's debt to equity has decreased by 8% YoY and by 4% QoQ
The company's equity rose by 8% YoY and by 3.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.